DNMT3A Mutations Occur Early or Late in Patients with Myeloproliferative Neoplasms and Mutation Order Influences Phenotype

Overview

Journal Haematologica

Specialty Hematology

Date 2015 Aug 8

PMID 26250577

Citations 65

Authors

Jyoti Nangalia

Francesca L Nice

David C Wedge

Anna L Godfrey

Jacob Grinfeld

Clare Thakker

Charlie E Massie

Joanna Baxter

David Sewell

Yvonne Silber

Peter J Campbell

Anthony R Green

Affiliations

Soon will be listed here.

Citing Articles

Biological Markers of Myeloproliferative Neoplasms in Children, Adolescents and Young Adults.

Ozygala A, Rokosz-Mierzwa J, Widz P, Skowera P, Wilinski M, Styka B Cancers (Basel). 2024; 16(23).

PMID: 39682300 PMC: 11640741. DOI: 10.3390/cancers16234114.

Initiating-clone analysis in patients with acute myeloid leukemia secondary to essential thrombocythemia.

Ushijima Y, Naruse S, Ishikawa Y, Kawashima N, Sanada M, Nakashima M Sci Rep. 2024; 14(1):15906.

PMID: 38987297 PMC: 11237009. DOI: 10.1038/s41598-024-66461-8.

Genomic evolution shapes prostate cancer disease type.

Woodcock D, Sahli A, Teslo R, Bhandari V, Gruber A, Ziubroniewicz A Cell Genom. 2024; 4(3):100511.

PMID: 38428419 PMC: 10943594. DOI: 10.1016/j.xgen.2024.100511.

Order-of-Mutation Effects on Cancer Progression: Models for Myeloproliferative Neoplasm.

Wang Y, Shtylla B, Chou T Bull Math Biol. 2024; 86(3):32.

PMID: 38363386 PMC: 10873249. DOI: 10.1007/s11538-024-01257-5.

Molecular Genetic Profile of Myelofibrosis: Implications in the Diagnosis, Prognosis, and Treatment Advancements.

Verma T, Papadantonakis N, Peker Barclift D, Zhang L Cancers (Basel). 2024; 16(3).

PMID: 38339265 PMC: 10854658. DOI: 10.3390/cancers16030514.

References

Kralovics R, Teo S, Li S, Theocharides A, Buser A, Tichelli A . Acquisition of the V617F mutation of JAK2 is a late genetic event in a subset of patients with myeloproliferative disorders. Blood. 2006; 108(4):1377-80. DOI: 10.1182/blood-2005-11-009605. View

Li J, Kent D, Chen E, Green A . Mouse models of myeloproliferative neoplasms: JAK of all grades. Dis Model Mech. 2011; 4(3):311-7. PMC: 3097453. DOI: 10.1242/dmm.006817. View

Moran-Crusio K, Reavie L, Shih A, Abdel-Wahab O, Ndiaye-Lobry D, Lobry C . Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation. Cancer Cell. 2011; 20(1):11-24. PMC: 3194039. DOI: 10.1016/j.ccr.2011.06.001. View

Abdel-Wahab O, Pardanani A, Rampal R, Lasho T, Levine R, Tefferi A . DNMT3A mutational analysis in primary myelofibrosis, chronic myelomonocytic leukemia and advanced phases of myeloproliferative neoplasms. Leukemia. 2011; 25(7):1219-20. PMC: 4640464. DOI: 10.1038/leu.2011.82. View

Stegelmann F, Bullinger L, Schlenk R, Paschka P, Griesshammer M, Blersch C . DNMT3A mutations in myeloproliferative neoplasms. Leukemia. 2011; 25(7):1217-9. DOI: 10.1038/leu.2011.77. View

Ko M, Bandukwala H, An J, Lamperti E, Thompson E, Hastie R . Ten-Eleven-Translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice. Proc Natl Acad Sci U S A. 2011; 108(35):14566-71. PMC: 3167529. DOI: 10.1073/pnas.1112317108. View

Rao N, Butcher C, Lewis I, Ross D, Melo J, Scott H . Clonal and lineage analysis of somatic DNMT3A and JAK2 mutations in a chronic phase polycythemia vera patient. Br J Haematol. 2011; 156(2):268-70. DOI: 10.1111/j.1365-2141.2011.08837.x. View

Challen G, Sun D, Jeong M, Luo M, Jelinek J, Berg J . Dnmt3a is essential for hematopoietic stem cell differentiation. Nat Genet. 2011; 44(1):23-31. PMC: 3637952. DOI: 10.1038/ng.1009. View

Fried I, Bodner C, Pichler M, Lind K, Beham-Schmid C, Quehenberger F . Frequency, onset and clinical impact of somatic DNMT3A mutations in therapy-related and secondary acute myeloid leukemia. Haematologica. 2011; 97(2):246-50. PMC: 3269485. DOI: 10.3324/haematol.2011.051581. View

10.

Nangalia J, Massie C, Baxter E, Nice F, Gundem G, Wedge D . Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2. N Engl J Med. 2013; 369(25):2391-2405. PMC: 3966280. DOI: 10.1056/NEJMoa1312542. View

11.

Shlush L, Zandi S, Mitchell A, Chen W, Brandwein J, Gupta V . Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia. Nature. 2014; 506(7488):328-33. PMC: 4991939. DOI: 10.1038/nature13038. View

12.

Lundberg P, Karow A, Nienhold R, Looser R, Hao-Shen H, Nissen I . Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms. Blood. 2014; 123(14):2220-8. DOI: 10.1182/blood-2013-11-537167. View

13.

Jaiswal S, Fontanillas P, Flannick J, Manning A, Grauman P, Mar B . Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J Med. 2014; 371(26):2488-98. PMC: 4306669. DOI: 10.1056/NEJMoa1408617. View

14.

Genovese G, Kahler A, Handsaker R, Lindberg J, Rose S, Bakhoum S . Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N Engl J Med. 2014; 371(26):2477-87. PMC: 4290021. DOI: 10.1056/NEJMoa1409405. View

15.

Ortmann C, Kent D, Nangalia J, Silber Y, Wedge D, Grinfeld J . Effect of mutation order on myeloproliferative neoplasms. N Engl J Med. 2015; 372(7):601-612. PMC: 4660033. DOI: 10.1056/NEJMoa1412098. View